Salvage radiation therapy and docetaxel (Taxotere) for biochemical failure after radical prostatectomy
Phase of Trial: Phase II
Latest Information Update: 08 Oct 2017
At a glance
- Drugs Docetaxel (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 02 Dec 2014 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
- 13 Jul 2012 Planned end date changed from 1 May 2012 to 1 May 2014 as reported by ClinicalTrials.gov.